JPRN-UMIN000052021
Completed
未知
A study for evaluating the immune response by ingestion of fermented plant extract - A study for evaluating the immune response by ingestion of fermented plant extract
ConditionsHealthy adult
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Healthy adult
- Sponsor
- EP Mediate Co., Ltd.
- Enrollment
- 36
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\)Subjects who use fermented plant extract containing food or food similar to fermented plant extract. (2\)Subjects routinely taking health supplements which may influence immune function. (3\)Subjects routinely taking health supplements which may influence bowel movement. (4\)Subjects taking medicine and quasi drug which may influence immune function. (5\)Subjects undergoing treatment related to fatigue, stress, and/or sleep. (6\)Subjects visiting the hospital for diseases related bowel movements and using drugs, or using commercial laxative. (7\)who are under medication which may influence the outcome of the study. (8\)Subjects having diseases affecting bowel movement or a history of these diseases. (9\)Subjects who have a history of the allergic disease. (10\)Subjects who have treated oral or dental care within the last one month prior to the current study or are planned to treat oral or dental care. (11\)Subjects who have oral or dental problems with bleeding. (12\)Night and day shift worker or manual laborer. (13\)Subjects who have carried out an intense activity (14\)Subjects who cannot carry out a procedure of various inspection by the rule during the study period. (15\)Subjects who have a disease under treatment or are judged to that medical treatment are necessary by the doctor. (16\)Subjects who have under treatment or a history of serious disease and disease to affect the adrenal cortical hormone secretion. (17\)Subjects having possibilities for emerging allergy related to the study. (18\)Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination. (19\)Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (20\)Subjects who are Participating in other clinical studies at the beginning of the present study. (21\)Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
A study to evaluate the immunogenicity and safety of smallpox vaccine as vaccination to monkeypox in healthy adultsJPRN-jRCTs031220171jiie Mugen50
Completed
Not Applicable
A study to evaluate the dose-response efficacy of body fat reduction by continuous ingestion of test food. (SWE-2023-07-HCRINK)ot applicableJPRN-UMIN000051748Suntory Wellness Limited200
Completed
Phase 2
The Study of Dose Response Relationship Evaluation of AryoSeven in Hemophilia PatientsCondition 1: Congenital Hemophilia A with inhibitors. Condition 2: Congenital Hemophilia B with inhibitors.Hereditary factor VIII deficiencyHereditary factor IX deficiencyIRCT20161202031193N3AryoGen Pharmed12
Completed
Not Applicable
A study to evaluate the dose-response effect of tolvaptan 7.5mg or 15mg in HF patients who undergo cartdiac angiographyHeart FailureJPRN-UMIN000009924Showa University Northern Hospital100
Completed
Not Applicable
A study to evaluate how the intake of the test beverage and the watching of a video while taking it impacts psychology and cognitive functioning.Healthy subjectsJPRN-UMIN000052562HUMA R&D CORP120